Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi inks cancer deal with Massachusetts General Hospital
Pharma Times, UK
Wednesday, October 10, 2012 - 11:50am
tags:
Sanofi, R&D, cancer, Massachusetts
Former Synthes Execs Excluded From Federal Healthcare Programs
Pharmalot
Wednesday, October 10, 2012 - 11:43am
tags:
JNJ, Synthes, Medicare, Medicaid
Lpath Restarts NEXUS Trial; Breathes New Life Into Shares
Seeking Alpha
Wednesday, October 10, 2012 - 11:42am
tags:
Lpath, iSONEP, wet-AMD
$1B Baxter Plant May Boost Potential Alzheimer's Drug
Forbes
Wednesday, October 10, 2012 - 11:41am
tags:
Baxter, Alzheimer's disease, Gammagard
MannKind's Breathtaking News
Motley Fool
Wednesday, October 10, 2012 - 11:39am
tags:
MannKind, Afrezza
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wednesday, October 10, 2012 - 11:37am
tags:
Eli Lilly, AstraZeneca, GSK, JNJ, Merck, Pfizer
Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial
Bloomberg
Wednesday, October 10, 2012 - 11:32am
tags:
Roche, Alzheimer's disease, Eli Lilly, solanezumab, gantenerumab
1 Pharma Receiving Nice News (NVS)
Motley Fool
Wednesday, October 10, 2012 - 11:16am
tags:
NICE, Novartis, Lucentis, DME, diabetic macular edema
Bad News For Pharma In World's Second-Biggest Market
Forbes
Wednesday, October 10, 2012 - 11:14am
tags:
China, emerging markets, India
Pfizer to pay $164 mln in investor lawsuit over Celebrex
Reuters
Wednesday, October 10, 2012 - 11:11am
tags:
Pfizer, investors, Celebrex
Savient Pharmaceuticals May Continue To Run Higher
Seeking Alpha
Tuesday, October 9, 2012 - 5:23pm
tags:
Savient, StemCells, Sarepta, Catalyst Pharmaceutical Partners, Hemispherx Biopharma
Optimer Pharma falls as Wall Street looks to Dificid price cut and marketing strategy
Yahoo/AP
Tuesday, October 9, 2012 - 5:22pm
tags:
Optimer Pharmaceuticals, Dificid
5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
Seeking Alpha
Tuesday, October 9, 2012 - 4:21pm
tags:
PLX, Pluristem Therapeutics, Ariad Pharmaceuticals, Ponatinib, Sarepta, eteplirsen, Fabry's disease, Amicus Therapeutics, StemCells
Five Cystic Fibrosis Questions for Vertex Pharma
TheStreet.com
Tuesday, October 9, 2012 - 4:16pm
tags:
cystic fibrosis, Vertex Pharma, Kalydeco, VX-809
Questcor Pharma rises following upgrade
Yahoo/AP
Tuesday, October 9, 2012 - 4:15pm
tags:
Questcor Pharmaceuticals, Acthar
Life Technologies Continues Acquisition Spree
Yahoo/Zacks.com
Tuesday, October 9, 2012 - 4:13pm
tags:
M&A, Life Technologies, Compendia Bioscience, Bristol-Myers Squibb, GSK
4 Reasons To Buy Horizon Pharma
Seeking Alpha
Tuesday, October 9, 2012 - 4:11pm
tags:
Horizon Pharma, Rayos
Why Merck's Earnings Are Outstanding
Motley Fool
Tuesday, October 9, 2012 - 4:10pm
tags:
earnings, Merck
Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?
Seeking Alpha
Tuesday, October 9, 2012 - 11:18am
tags:
cervical cancer, Merck, GSK, Inovio, Sarepta Therapeutics, Synageva
J&J eyes new Doxil process to reverse shortage
Fierce Pharma
Tuesday, October 9, 2012 - 11:16am
tags:
Doxil, JNJ, drug shortages, FDA, EMA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.